These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15472128)

  • 1. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice.
    de Nooijer R; von der Thüsen JH; Verkleij CJ; Kuiper J; Jukema JW; van der Wall EE; van Berkel JC; Biessen EA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2313-9. PubMed ID: 15472128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
    Sukhova GK; Wang B; Libby P; Pan JH; Zhang Y; Grubb A; Fang K; Chapman HA; Shi GP
    Circ Res; 2005 Feb; 96(3):368-75. PubMed ID: 15653570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.
    Bot I; von der Thüsen JH; Donners MM; Lucas A; Fekkes ML; de Jager SC; Kuiper J; Daemen MJ; van Berkel TJ; Heeneman S; Biessen EA
    Circ Res; 2003 Sep; 93(5):464-71. PubMed ID: 12919945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
    de Nooijer R; Verkleij CJ; von der Thüsen JH; Jukema JW; van der Wall EE; van Berkel TJ; Baker AH; Biessen EA
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):340-6. PubMed ID: 16306430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
    Schober A; Bernhagen J; Thiele M; Zeiffer U; Knarren S; Roller M; Bucala R; Weber C
    Circulation; 2004 Jan; 109(3):380-5. PubMed ID: 14691040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
    Schober A; Knarren S; Lietz M; Lin EA; Weber C
    Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques.
    Fukumoto Y; Deguchi JO; Libby P; Rabkin-Aikawa E; Sakata Y; Chin MT; Hill CC; Lawler PR; Varo N; Schoen FJ; Krane SM; Aikawa M
    Circulation; 2004 Oct; 110(14):1953-9. PubMed ID: 15451791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity.
    Lessner SM; Martinson DE; Galis ZS
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2123-9. PubMed ID: 15308548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method of plaque rupture induction in apolipoprotein E-deficient mice.
    Sasaki T; Kuzuya M; Nakamura K; Cheng XW; Shibata T; Sato K; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1304-9. PubMed ID: 16574894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
    Isoda K; Sawada S; Ishigami N; Matsuki T; Miyazaki K; Kusuhara M; Iwakura Y; Ohsuzu F
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1068-73. PubMed ID: 15059807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
    Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
    J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement.
    Tang YL; Yang YZ; Wang S; Huang T; Tang CK; Xu ZX; Sun YH
    Chin Med J (Engl); 2009 Feb; 122(3):319-25. PubMed ID: 19236812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
    Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H
    Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice.
    Shi W; Brown MD; Wang X; Wong J; Kallmes DF; Matsumoto AH; Helm GA; Drake TA; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1901-6. PubMed ID: 12920047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.
    Cheng C; Tempel D; van Haperen R; van der Baan A; Grosveld F; Daemen MJ; Krams R; de Crom R
    Circulation; 2006 Jun; 113(23):2744-53. PubMed ID: 16754802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
    Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
    Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
    Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.